Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05936294 · ClinicalTrials.gov registry record · NA
Adaptive Cardiac Resynchronization Therapy in Patients With RBBB
A NA study, sponsored by Henry Ford Health System.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05936294 is a NA study that was terminated before completion, run by Henry Ford Health System. The registered enrollment target is 5 participants.
The verdict
NCT05936294, a NA study, was terminated before completion, sponsored by Henry Ford Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will address whether acute adaptive RV pacing in sinus rhythm patients with severe LV systolic dysfunction and RBBB is superior to no ventricular pacing, and is as effective as echocardiographically optimized biventricular (BIV) pacing based on Medtronic ECG belt and cardiac performance as assessed by the echocardiographic parameters of RV and LV function.
Interventions
- DIAGNOSTIC_TEST Optimization of CRT Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05936294
The ClinicalTrials.gov registry entry for NCT05936294 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optimization of CRT Device is the first listed.
NCT05936294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05936294 about?
NCT05936294 is a clinical study titled "Adaptive Cardiac Resynchronization Therapy in Patients With RBBB". This study will address whether acute adaptive RV pacing in sinus rhythm patients with severe LV systolic dysfunction and RBBB is superior to no ventricular pacing, and is as effective as echocardiographically optimized biventricular (BIV) pacing based on Medtronic ECG belt and cardiac performance a...
What is the current status of trial NCT05936294?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2017-09-15. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT05936294?
The interventions under investigation include: Optimization of CRT Device (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05936294?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.